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ABSTRACT
Short interfering RNAs (siRNAs) and microRNAs
(miRNAs) have been widely used in mammalian
tissue culture and model organisms to selectively
silence genes of interest. One limitation of this technology is the lack of precise external control over
the gene-silencing event. The use of photocleavable
protecting groups installed on nucleobases is a
promising strategy to circumvent this limitation,
providing high spatial and temporal control over
siRNA or miRNA activation. Here, we have
designed,
synthesized
and
site-specifically
incorporated new photocaged guanosine and
uridine RNA phosphoramidites into short RNA
duplexes. We demonstrated the applicability of
these photocaged siRNAs in the light-regulation of
the expression of an exogenous green fluorescent
protein reporter gene and an endogenous target
gene, the mitosis motor protein, Eg5. Two different
approaches were investigated with the caged RNA
molecules: the light-regulation of catalytic RNA
cleavage by RISC and the light-regulation of seed
region recognition. The ability to regulate both
functions with light enables the application of this
optochemical methodology to a wide range of small
regulatory RNA molecules.
INTRODUCTION
Light irradiation is an excellent external trigger to afford
high-resolution control over biological processes, as
irradiation can be precisely controlled in time, space and
amplitude. One approach to regulate the activity of a
biologically functional molecule with light is through the
installation of a photocleavable protecting group onto the

molecule, thereby rendering it inactive—a process that has
been termed ‘caging’ (1–8). A brief irradiation with nondamaging UV light removes the caging group and restores
activity of the biomolecule. This methodology has been
successfully applied to the light-regulation of gene expression through caged antisense agents (9–14), caged mRNA
(15), caged DNA decoys (16), caged triplex-forming oligonucleotides (17), caged proteins (18–20), caged small molecules (21,22) and recently to caged miRNA antagomirs
(23,24).
Short interfering RNAs (siRNAs) are powerful genesilencing tools that have been widely applied to the
study of gene function and gene regulation (25,26).
Consisting 19–21 nucleotides, siRNAs are doublestranded RNAs that are processed through the RNA
interference pathway to inhibit gene expression in a
sequence-speciﬁc manner (27). siRNAs are typically
either transfected or injected into cells, and on entrance
into RISC, the 50 phosphate of the antisense strand is
bound within the PIWI domain of argonaute (28). The
catalytic domain of argonaute subsequently cleaves the
sense strand, which is then removed from RISC.
Structural studies have shown that the anchored antisense
strand remains in a helical conformation within RISC
(29). This exposes the seed region, nucleotides 2–8, to
site-speciﬁcally bind to the mRNA target, providing the
basis for initial target site recognition. siRNAs, in contrast
to miRNAs, are completely complementary to the mRNA
target, which is cleaved at nucleotides 10–11 of the antisense strand by the catalytic subunit of argonaute,
followed by further degradation outside of RISC (30).
Through kinetic studies of RISC, it was concluded that
the A-form helix of the siRNA:mRNA duplex in RISC
is essential for siRNA activity (31). The replacement of
an essential nucleobase with a mismatched nucleotide
into the antisense strand creates a ‘bulge’ within the
siRNA:mRNA duplex and can render the siRNA completely inactive owing to the structural distortion of the
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A-form (32). Consequently, the maintenance of this structural motif for mRNA recognition is a viable target for
a caging strategy.
Recently, different caging approaches have been
applied to the optochemical regulation of siRNA
function. For example, Friedman et al. incorporated sterically
demanding
cyclo-dodecyl-4,5-dimethoxy-2nitrophenylethyl groups at each terminus of the siRNA
(33), thus rendering the siRNA molecule inactive until
UV irradiation restored 80% of gene-silencing activity.
The 4,5-dimethoxy-2-nitrophenylethyl (DMNPE) caging
group was incorporated non-speciﬁcally throughout 20
ﬂuoro-siRNA by Monroe et al. to achieve optochemical
control over siRNA activity (34). The DMNPE-caged 20
ﬂuoro-siRNAs did not show full inhibition of siRNA
function, and siRNA activity could not be completely
restored through UV irradiation. However, functionality in a zebraﬁsh model system was demonstrated.
In a third approach, Heckel et al. incorporated a
2-(2-nitrophenyl)propyl (NPP)-caged deoxyguanosine
nucleotide into the antisense strand of an siRNA (35).
By NPP-caging one of the nucleotides at position 9–11,
siRNA activity was reduced to 10%. However, some
instability of the caging group was observed, as increased
RNAi activity was apparent after 28 h in cells that were
kept in the dark.
Here, we report the ﬁrst synthesis of 6-nitropiperonyloxymethyl (NPOM)-caged guanosine and uridine
phosphoramidites and their site-speciﬁc incorporation
into siRNA reagents that are composed of ribonucleic
acids at the caging sites. The caged siRNA is expected
to be functionally inactive and not silence gene expression
until a brief UV exposure removes the caging groups and
activates the siRNA reagent resulting in gene silencing
(Scheme 1). We initially tested the light-activation of
siRNAs with a green ﬂuorescent protein (GFP) reporter
as a proof-of-concept, but subsequently demonstrated the
light-activation of endogenous Eg5 silencing. Eg5 is a

A

B

mitosis motor protein involved in spindle formation and
movement in cell division (36–38). The inhibition of Eg5
leads to a binucleated cell phenotype (39). This, for the
ﬁrst time, demonstrated the applicability of light-activated
RNAi in the silencing of an endogenous gene via a
photocaged RNA nucleobase strategy.
Multiple sites within an siRNA reagent are conceivable
targets for the installation of caging groups to
optochemically regulate its function. We selected two different sites for the introduction of our NPOM-caged
nucleotides: (i) within the seed region of the siRNA (nucleotides 2–8, Scheme 1B) and (ii) surrounding the
argonaute cleavage site of the siRNA bound to RISC
(nucleotides 9–11, Scheme 1A) (31). The seed region of
the small non-coding RNA is an important motif found
in both siRNAs and miRNAs, guiding the reagents to
their target mRNAs. However, a major difference
between both classes of gene-silencing agents is that
miRNAs do not cleave their target mRNA due to the
typical incomplete sequence complementarity between
the miRNA and its target, but rather suppresses the translation of the target gene (40). In contrast, RNA cleavage
by argonaute commonly occurs in the case of perfect
homology between siRNA and mRNA target sequences
(41,42). For this reason, the introduction of caging groups
within the seed region is an attractive tool not only for the
light-regulation of siRNAs but also of miRNAs. Based on
the prevalence of guanosine and uridine nucleotides within
the seed region (nucleotides 2–8) and at the argonaute
cleavage site (nucleotides 9–11) within the selected
siRNA reagents, novel NPOM-caged guanosine and
NPOM-caged uridine phosphoramidites were synthesized,
as discussed later in the text. The availability of both
NPOM-caged guanosine and NPOM-caged uridine
building blocks affords the needed ﬂexibility for
sequence selection for caging group installation. The
site-speciﬁc installation of NPOM-caged nucleotides at
speciﬁc positions allowed us to conﬁrm that base-pairing
at these nucleotides with the mRNA target is essential
for siRNA activity and therefore represents a general
approach to the generation of light-activated siRNAs.
MATERIALS AND METHODS
RNA synthesis protocol

caged
seed region

RISC
UV

UV

caged catalytic site

gene silencing

Scheme 1. Two siRNA light-activation approaches. Caged nucleotides
are positioned (A) near the cleavage site or (B) at the seed region of the
siRNA agent, leading to gene expression by preventing RISC cleavage
or mRNA target recognition. On UV irradiation, the caging groups are
cleaved resulting in the silencing of gene expression through RNA
interference.

GFP siRNA was purchased from Dharmacon. Non-caged
and caged RNA synthesis was performed using an Applied
Biosystems 394 Automated DNA/RNA Synthesizer
(Foster City, CA, USA) and standard b-cyanoethyl
phosphoramidite chemistry. The caged siRNAs were
synthesized using 40-nmole scale, low volume solid phase
supports obtained from Glen Research (Sterling, VA,
USA). Reagents for automated RNA synthesis were also
obtained from Glen Research. Standard synthesis cycles
provided by Applied Biosystems were used for all normal
bases using 2 min coupling times. The coupling time
was increased to 10 min for the positions at which the
caged-U- and caged-G-modiﬁed phosphoramidites were
incorporated. Each synthesis cycle was monitored by following the release of dimethoxytrityl (DMT) cations after
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each deprotection step. No signiﬁcant loss of DMT was
noted following the addition of the caged-U or caged-G
to the RNA, so 10 min was sufﬁcient to allow maximal
coupling of the caged nucleotides. Yields of caged RNAs
were close to theoretical values routinely obtained.
Melting temperatures
The melting temperature (Tm) of each siRNA was
measured using a Cary 100 Bio UV/Vis spectrometer
with a temperature controller (Varian). The two complementary strands of siRNAs (1 mM) were incubated in
0.15 M NaCl, 0.05 M NaH2PO4, pH 7.2, buffer. The
samples were protected from light or irradiated at
365 nm with a UV transilluminator (3 mW cm2) for
20 min, heated to 100 C for 2 min, and then cooled to
20 C at a rate of 2 C/min, held at 20 C for 5 min and
then heated to 100 C at a rate of 2 C/min. Absorbance
was recorded at 260 nm every 1 C. The Tm was determined
by the maximum of the ﬁrst derivative of the absorbance
versus temperature plot. Standard deviations were
calculated from three individual experiments.
Flow cytometry analysis
Human embryonic kidney (HEK) 293T cells were grown
at 37 C, 5% CO2 in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Hyclone), supplemented with 10% fetal bovine
serum (Hyclone) and 10% streptomycin/penicillin (MP
Biomedicals). Cells were passaged into 24-well plates
(1 ml per well, 4  104 cells per well) and grown to
70% conﬂuence within 24 h. The medium was changed
to OPTIMEM (Invitrogen), and the cells were transfected
with 0.5 mg pEGFP-N1 (Clontech) and 0.5 mg pDsRed-N1
monomer (Clontech) and 40 pmol siRNAs with XtremeGENE siRNA reagent (3:2 reagent/RNA ratio,
Roche). All transfections were performed in triplicate.
Cells were incubated at 37 C for 4 h, the transfection
medium was removed and 1 ml phosphate buffered
saline (PBS, pH 7.4) was added. The cells were irradiated
for 5 min on a UV transilluminator (365 nm, 3 mW cm2).
PBS was removed and DMEM media was added, followed
by a 48-h incubation at 37 C, 5% CO2, and the cells
(20 000) were assayed for ﬂuorescence by ﬂow cytometry.
Analysis was performed on a FACSCalibur (BectonDickinson) instrument, using a 488-nm excitation laser
with a 530-nm band pass ﬁlter (GFP) and a 633-nm excitation argon laser and 661-nm band pass ﬁlter (DsRed).
Fluorescence was analyzed using the Cellquest Pro
Software. For each of the triplicates, the data were
averaged, and standard deviations were calculated.
Phenotypic Eg5 inhibition assay
HeLa cells were grown at 37 C, 5% CO2 in DMEM
(Hyclone), supplemented with 10% fetal bovine serum
(Hyclone) and 10% streptomycin/penicillin (MP
Biomedicals). Cells were passaged into 4-well chamber
slide (1 ml/well, 4  104 cells/well) and grown to 70%
conﬂuence within 24 h. The medium was changed to
OPTIMEM (Invitrogen) and the cells were transfected
with 40 pmol siRNAs with X-tremeGENE siRNA
reagent (3:2 reagent/RNA ratio, Roche). Cells were

incubated at 37 C for 4 h, the transfection medium was
removed and 0.25 ml PBS (pH 7.4) was added. The cells
were irradiated for 5 min on a UV transilluminator
(365 nm, 3 mW cm2). DMEM media was added, and the
cells were incubated at 37 C, 5% CO2 for 48 h. The cells
were ﬁxed with formaldehyde (3.75%) and permeabilized
with Triton-100x, strained with Alexa Fluor 488 Phalloidin
(ex/em 488 nm/495–630 nm, Invitrogen) and 40 ,6diamidino-2-phenylindole (DAPI) (ex/em 405 nm/410–
495 nm, Invitrogen). Cells were imaged on a Zeiss LSM
710 confocal microscope (40 oil objective).
Quantitative real time-polymerase chain reaction
HeLa cells were passaged into six-well plates (2 ml per
well, 2  105 cells per well) and grown to 70% conﬂuence within 24 h. The medium was changed to OPTIMEM
(Invitrogen), and the cells were transfected with 40 pmol
siRNAs with X-tremeGENE siRNA reagent (3:2 reagent/
RNA ratio, Roche). All transfections were performed in
triplicate. Cells were incubated at 37 C for 4 h, the transfection medium was removed and 1 mL PBS (pH 7.4) was
added. The cells were irradiated for 5 min on a UV
transilluminator (365 nm, 3 mW cm2). DMEM media
was added, and the cells were incubated at 37 C, 5%
CO2 for 48 h. RNA was isolated with TRIZOL reagent
(Invitrogen). cDNAs were synthesized with Superscript
Reverse Transcriptase II (Invitrogen) and quantitative
real time-polymerase chain reactions (RT-PCRs) were
performed with Eg5 forward primer 50 CAGCTGAAAA
GGAAACAGCC, Eg5 reverse primer 50 ATGAACAAT
CCACACCAGCA (37), GAPDH forward primer 50 TGC
ACCACCAACTGCTTAGC and GAPDH reverse primer
50 GGCATGGACTGTGGTCATGAG (43). The threshold cycles of each sample were normalized to the GAPDH
housekeeping gene, and the inhibition of gene silencing
is represented as percentage of Eg5 expression. For each
of the triplicates, the data were averaged, and standard
deviations were calculated.
RESULTS
Synthesis of NPOM-caged guanosine and uridine
phosphoramidites
Caged guanosine and uridine RNA phosphoramidites
were prepared to synthesize caged RNA oligonucleotides
and to site-speciﬁcally incorporate caged nucleotides into
siRNA reagents. The silyl-protected guanosine 2 was
synthesized from the guanosine derivative 1 in 2 steps
(Scheme 2). After selectively protecting both the 50 and 30
hydroxy groups, a speciﬁc modiﬁcation of the 20 hydroxyl
group with tert-butyldimethylsilyl group (TBDMS) was
possible, yielding 2 (44,45). Subsequently, the NPOM
caging group was installed through alkylkation of the
N1 position of the guanine ring with 3 (46) in the
presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in
dimethylformamide (DMF), affording 4 in 79% yield.
Selective deprotection of the 30 and 50 hydroxyl groups
was achieved with HF-pyridine at 0 C, resulting in the
caged nucleoside 5 in 89% yield. Installation of the DMT
group at the 50 position of 5 with dimethoxytrityl chloride
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Scheme 2. Synthesis of the NPOM-caged guanosine phosphoramidite 7 from commercially available 1. Dimethylformamide (DMF), tertbutyldimethylsilyl chloride (TBDMSCl), dichloromethane (DCM), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), di(p-methoxyphenyl)phenyl-methyl
chloride (DMTCl) and tetrahydrofuran (THF).

(DMTCl) provided 6 in 83% yield, followed by the activation of the 30 hydroxy group with 2-cyanoethyl-N,Ndiisopropyl-chlorophosphoramidite in THF, delivering
the NPOM-caged guanosine phosphoramidite 7 in 56%
yield.
To expand the ﬂexibility of this RNA light-activation
approach by increasing the number of potential caging
sites, the NPOM-caged uridine phosphoramidite 11 was
designed (Scheme 3). The silyl-protected uridine 9 was
synthesized from uridine (8) in 97% yield. The nucleobase
in 9 was then reacted with NPOM chloride (3) in the
presence of Cs2CO3 in DMF, producing 10 in 77% yield.
Selective removal of the 50 and 30 hydroxy protecting group
furnished the caged uridine nucleoside 11 in 77% yield.
The 50 hydroxy group was then readily converted to the
DMT ether 12 in 88% yield, and the 30 hydroxy group
was reacted with 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite in N,N-diisopropylethylamine (DIPEA) and
DCM in 91% yield to produce the NPOM-caged uridine
phosphoramidite 13.
Polymerization and hybridization of NPOM-caged
siRNA reagents
After successful synthesis of both RNA phosphoramidites
7 and 13, caged antisense strands were synthesized by
incorporating the NPOM-caged nucleotides into synthetic
siRNAs using standard RNA synthesis conditions on an
Applied Biosystems DNA/RNA synthesizer. Based on
Rana’s and Heckel’s chemical modiﬁcation study of
siRNAs (35,47), caged RNA phosphoramidites were
incorporated into positions ﬂanking the site of mRNA
cleavage, nucleotides 9–11 (Figure 1). These previous
studies (35,47) hypothesized that the caged nucleobase
creates a bulge within the siRNA/mRNA duplex by sitespeciﬁcally inhibiting Watson–Crick base pair formation
without completely preventing hybridization of the two
strands. This perturbation of the A-form conformation
of the RNA interferes with the argonaute cleavage mechanism. In an alternate approach, caged uridine nucleotides
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Scheme 3. Synthesis of the NPOM-caged uridine phosphoramidite
13 from 8. Dimethylformamide (DMF), tert-butyldimethylsilyl
chloride (TBDMSCl), dichloromethane (DCM), di(p-methoxyphenyl)phenyl-methyl chloride (DMTCl), tetrahydrofuran (THF) and
N,N-diisopropylethylamine (DIPEA).
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ΔT m

−

−

−

5’CAAGCUGACCCUGAAGUUCdTdT
dTdTGUUCGACUGGGACUUCAAG-5’

75.7 ± 0.8

−

−

CGFP-1

5’CAAGCUGACCCUGAAGUUCdTdT
dTdTGUUCGACUGGGACUUCAAG-5’

61.6 ± 1.0

68.5 ± 1.3

6.9

CGFP-2

5’CAAGCUGACCCUGAAGUUCdTdT
dTdTGUUCGACUGGGACUUCAAG-5’

59.3 ± 1.4

71.1 ± 1.5

11.8

CGFP-3

5’CAAGCUGACCCUGAAGUUCdTdT
dTdTGUUCGACUGGGACUUCAAG-5’

70.1 ± 0.1

74.7 ± 0.6

4.6

CGFP-4

5’CAAGCUGACCCUGAAGUUCdTdT
dTdTGUUCGACUGGGACUUCAAG-5’

67.4 ± 0.1

70.8 ± 0.9

3.4

Eg5

5’CAACAAGGAUGAAGUCUAUdTdT
dTdTGUUGUUCCUACUUCAGAUA-5’

65.1 ± 0.1

−

−

CEg5-1

5’CAACAAGGAUGAAGUCUAUdTdT
dTdTGUUGUUCCUACUUCAGAUA-5’

57.6 ± 0.7

65.2 ± 0.8

7.6

CEg5-2

5’CAACAAGGAUGAAGUCUAUdTdT
dTdTGUUGUUCCUACUUCAGAUA-5’

47.4 ± 0.7

61.5 ± 0.7

14.1

CEg5-3

5’CAACAAGGAUGAAGUCUAUdTdT
dTdTGUUGUUCCUACUUCAGAUA-5’

58.8 ± 0.8

64.7 ± 0.0

5.9

CEg5-4

5’CAACAAGGAUGAAGUCUAUdTdT
dTdTGUUGUUCCUACUUCAGAUA-5’

66.7 ± 0.8

67.7 ± 0.7

1

CEg5-5

5’CAACAAGGAUGAAGUCUAUdTdT
dTdTGUUGUUCCUACUUCAGAUA-5’

57.9 ± 0.0

64.7 ± 0.0

6.8

Sequence

CNTRL

5’UACGCUGAGUACUUCGAUUdTdT
dTdTAUGCGACUCAUGAAGCUAA-5’

GFP

− UV

T m / °C
+ UV

Name

Figure 1. Sequences and Tm of caged siRNAs. Bold and underLined G denotes a caged guanosine nucleotide from the incorporation of 7 and a bold and
underLined U denotes a caged uridine nucleotide from the incorporation of 13. Standard deviations were calculated form three individual experiments.

were installed within the seed region, nucleotides 2–8, of
the siRNA to prevent recognition of the target mRNA. In
all cases, the caged siRNA sequences were designed to still
maintain an RNA duplex with their complement at 37 C,
as conﬁrmed by Tm measurements (Figure 1 and
Supplementary Information). The non-modiﬁed GFP
siRNA duplex exhibits a Tm of 76 C. The addition of a
single caged guanosine nucleotide at position 10 of the
antisense strand CGFP-1 displayed a Tm of 62 C, 14 C
lower than the non-caged GFP siRNA duplex. Therefore,
while hybridization was observed, the RNA duplex was
slightly perturbed resulting in a decreased Tm. When two
caged guanosine nucleotides were installed at positions 9
and 11 of the antisense strand CGFP-2, a similar effect
was observed and the Tm decreased to 59 C. The incorporation of caged uridine nucleotides within the seed region
did not affect the Tm to the same extent as the incorporation of caging groups closer to the center of the RNA
antisense strand. For example, installation of the NPOMcaged uridine at nucleotide 5 in CGFP-3 led to a Tm of
70 C, only 6 C lower than the non-caged GFP siRNA.
The incorporation of two caged uridine nucleotides at positions 5 and 6 in the antisense strand CGFP-4 provided a
Tm of 67 C, indicating that the addition of a second
caging group in the seed region only minimally induces
further disruption of hybridization of the entire 19-mer.
These results are comparable to previously caged

double-stranded oligonucleotides in that the installation
of one or two caged nucelobases can have a negligible
effect on the Tm of an oligomer. Complete inhibition of
duplex formation would require a caging group every ﬁve
or six nucleobases (10,48). Here, all synthesized siRNA
duplexes maintained a desired hybridization at 37 C
despite the incorporation of 1–3 caged nucleotides.
As expected, UV-induced caging group removal yielded
double-stranded RNA molecules that displayed increased
Tm comparable with the Tm of the non-caged GFP
siRNA (Figure 1). The observed slightly lower Tm after
UV exposure compared with the non-caged duplex could
be the result of incomplete deprotection of the bulk
sample.
In a design strategy following the GFP siRNA, NPOMcaged uridine phosphoramidites were incorporated at the
cleavage site and the seed region of the antisense strand of
the Eg5 siRNA and Tm were measured to ensure hybridization (Figure 1). The installation of a single caging
group at nucleotide 11 of the antisense strand CEg5-1
resulted in a Tm of 58 C, displaying only a 7 C decrease
in Tm compared with the Eg5 siRNA, which had a Tm of
65 C. The incorporation of two NPOM-caged uridine
residues at nucleotides 8 and 11 in CEg5-2 resulted in a
Tm of 48 C. Introduction of a single NPOM-caged uridine nucleotide within the seed regions of CEg5-3 and
CEg5-4 resulted in a Tm of 59 and 64 C, respectively.
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The installation of two NPOM-caged uridine nucleotides
within the seed region of the siRNA (CEg5-5) led to a Tm
of 58 C. As observed for the GFP siRNA reagents, the
presence of NPOM-caged uridine nucleotides in the Eg5
siRNA sequence resulted in only a slight perturbation of
the RNA:RNA duplex structure without loss of hybridization at 37 C. After UV irradiation, the caging groups
are removed, and increased Tm, comparable to that of the
non-caged Eg5 siRNA, were observed. No signiﬁcant differences in Tm were observed for the nucleobase-caging
of uridine versus guanosine, supporting the generality
and predictability of our oligonucleotide light-activation
approach.

A CNTRL

B GFP

C CGFP-1

EGFP
− UV
DsRed

EGFP
+ UV

Light-activation of siRNA reagents targeting GFP
To test the activity of the caged siRNAs in mammalian cell
culture, we ﬁrst targeted the reporter gene GFP and used
DsRed as a transfection control for ﬂuorescent signal normalization. HEK 293T cells were co-transfected with
pEGFP-N1, pDsRed-N1 monomer and the corresponding
caged and non-caged duplex siRNA. After transfection,
the cells were either irradiated for 5 min (365 nm, 25 W)
or kept in the dark, followed by incubation for 48 h.
The cells were then imaged and GFP and DsRed expression was quantiﬁed using ﬂow cytometry. The number of
cells expressing both GFP and DsRed was normalized to
cells expressing only DsRed. A scrambled siRNA was used
as a negative control (CNTRL) and, as expected, showed
no inhibition of GFP expression (Figure 2A and G). Cells
treated with the GFP siRNA (positive control) displayed
a 90% reduction of GFP expression (Figure 2B). In
the presence of the single NPOM-caged guanosine nucleotide in CGFP-1, 82% GFP expression was observed
(Figure 2C), indicating that the caged siRNA reagent was
inactive due to the presence of the caging group close to the
argonaute cleavage site. The incorporation of two caged
guanosine nucleotides in CGFP-2 resulted in complete
inhibition of siRNA activity before irradiation, as GFP
expression levels identical with the negative control were
observed (Figure 2D). After a brief irradiation with UV
light (365 nm), the caging groups were removed, activating
CGFP-1 and CGFP-2, and resulting in the silencing of
GFP expression to 20–30% of native levels (comparable
to the non-caged analogs). An irradiation time course
was performed and no difference in GFP silencing
was observed between a 2-min and a 10-min irradiation
(see Supporting Information). Thus, by installing the
NPOM-caged guanosine nucleotides within the central
region of the siRNA duplex, mRNA silencing by
argonaute is inhibited until light-induced removal of the
caging group(s), effectively creating UV-activated siRNA
reagents.
The seed region of non-coding RNAs, like siRNAs and
miRNAs, is essential in the recognition of their target genes
(49). Therefore, NPOM-caged uridine nucleotides were
introduced within the seed region of siRNAs to determine
whether this approach is also viable for the development
of light-activatable siRNAs by speciﬁcally disrupting
the siRNA:mRNA interaction and not necessarily the
mRNA-cleavage activity of RISC. Having two validated

DsRed

D

CGFP-2

E

CGFP-3

F

CGFP-4

EGFP
− UV
DsRed

EGFP
+ UV
DsRed

G

Figure 2. Photoactivated RNA interference in mammalian cells.
HEK 293T cells were transfected with pEGFP-N1, pDsRed-N1
monomer and siRNA oligonucleotides. Cells were irradiated for
5 min (25 W, 365 nm) or kept in the dark. (A–F) Cells were imaged
after 48 h. The GFP channel is shown above the DsRed channel.
(G) After a 48-h incubation, the cells were trypsinized and analyzed
by ﬂow cytometry. The number of cells expressing both GFP and
DsRed was normalized to the number of cells expressing only
DsRed. Standard deviations were calculated from three individual
experiments.
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approaches to the light-regulation of RNA interference will
provide greater ﬂexibility in the design and synthesis of
caged non-coding RNA reagents and will allow for the generation of light-activated RNA molecules that do not rely
on argonaute cleavage, e.g. miRNAs. Gratifyingly, the
caged siRNA duplex CGFP-3, bearing one caged uridine
in the seed region, was virtually inactive in HEK 293T cells,
as 82% of GFP expression was observed (Figure 2E). On
addition of a second caging group in CGFP-4, complete
inactivation of siRNA activity was observed, identical to
the negative control siRNA (Figure 2F). After UV
exposure, the silencing activity of the siRNAs was
restored with only 19 and 36% GFP expression observed
for CGFP-3 and CGFP-4, respectively (Figure 2G). These
results indicate that two different caging approaches—
installation of caging groups close to the argonaute
cleavage site or in the RNA seed region—can be used to
generated light-activated siRNA reagents with excellent
‘off’ to ‘on’ switching ratios, resembling those of negative
and positive control reagents.
Light-activation of siRNA reagents targeting Eg5
Next, the light-activation of caged siRNA reagents targeting the endogenous Eg5 gene was tested in mammalian cell
culture. HeLa cells were transfected with the caged Eg5
siRNAs (50), and the cells were either brieﬂy irradiated
with UV light (5 min, 25 W, 365 nm) or kept in the dark.
After a 48-h incubation, the cells were ﬁxed, stained with
Alexa Fluor 488 phalloidin (to label actin ﬁlaments) and
DAPI (to label nuclei) and imaged by confocal microscopy. The negative control siRNA sequence displayed
no obvious change in phenotype (Figure 3A) in the
presence or absence of UV irradiation. As expected, Eg5
siRNA transfected cells led to a binucleated phenotype
due to Eg5 silencing and cell cycle arrest within mitosis
(50,51), with most cells showing 2–3 nuclei (Figure 3B).
CEg5-1 and CEg5-2 containing NPOM-caged uridine
nucleotides within the central argonaute-cleavage region
of the siRNA displayed a phenotype identical to the
negative control when kept in the dark, indicating that
the caged Eg5 siRNA reagents are functionally inactive
(Figure 3C and D). After a brief irradiation (5 min,

A CNTRL

B

Eg5

C CEg5-1

25 W, 365 nm), binucleated cells were observed, showing
a phenotype identical to cells treated with the Eg5 siRNA
positive control. This indicates that the siRNA reagents
were optochemically activated for suppression of Eg5
expression. Moreover, the incorporation of a single
caged NPOM-caged uridine nucleotide within the seed
region, as in CEg5-3 and CEg5-4, functionally inactivated
the siRNA, leading exclusively to a normal cell phenotype
(Figure 3E and F, respectively). Upon irradiation, the
Eg5-knockdown phenotype is observed as a result of
light-activation of the siRNA molecules. As expected,
the introduction of a second NPOM-caged uridine nucleotide within the seed region of CEg5-5 also fully inactivated
the siRNA (Figure 3G), and activity was again restored
through UV exposure. These results demonstrate, for
the ﬁrst time, the application of caged siRNA in the
light-induced silencing of an endogenous gene.
To quantify the optochemically induced Eg5 gene
silencing, total RNA isolated from cells transfected with
the corresponding siRNAs and either irradiated or kept in
the dark was subjected to quantitative real-time PCR
analysis (37). Eg5 expression was normalized to the
endogenous housekeeping gene GAPDH and the inactive
negative control siRNA was set to 100%. In agreement
with the previous phenotypic observations, the negative
control siRNA (CNTRL) did not inhibit Eg5 expression,
whereas the Eg5 positive control siRNA silenced expression to 8% (Figure 4). The incorporation of an
NPOM-caged uridine nucleotide within the central
argonaute-cleavage region of the siRNA (CEg5-1)
renders the siRNA mostly inactive with 74% Eg5 expression detected. The addition of a second caged nucleotide
within this region (CEg5-2) completely inactivates the
siRNA, with 98% Eg5 expression observed. UV irradiation restores Eg5 siRNA activity of both CEg5-1 and
CEg5-2 to the same extent, with only 24% Eg5 mRNA
levels detected. The introduction of NPOM-caged uridine
nucleotides within the seed region of the siRNA, as in
CEg5-3 and Eg5-4, also led to the inactivation of the
siRNA with 79 and 91% of Eg5 expression observed,
respectively. After a brief UV irradiation, the caging
groups are cleaved, activating the siRNA, and leading to
the inhibition of Eg5 with only 18 and 24% of residual

D CEg5-2

E CEg5-3

F

CEg5-4

G CEg5-5

− UV

+ UV

Figure 3. Optochemical activation of Eg5 siRNA in HeLa cells. HeLa cells were transfected with caged and non-caged siRNAs (40 pmol). The cells
were irradiated (5 min, 25 W, 365 nm) and incubated at 37 C, 5% CO2 for 48 h. (A–G) The cells were ﬁxed and stained with Alexa Fluor 488
phalloidin (green) and DAPI (blue). The cells were imaged on a Zeiss LSM 710 confocal microscope using a 40 oil objective and Alexa Fluor 488
and DAPI-speciﬁc lasers (488 nm multiline argon and 405 nm diode).

Nucleic Acids Research, 2013, Vol. 41, No. 22 10525

Figure 4. Quantiﬁcation of photoactivation of Eg5 siRNA. HeLa cells
were transfected with siRNAs, and after 48-h incubation, the RNA was
extracted and quantitative real-time PCR analysis was performed. Eg5
expression was normalized to the expression of the GAPDH housekeeping gene, and the negative control was set to 100% Eg5 expression.
Error bars represent standard deviations from three independent
experiments.

Eg5 expression observed for CEg5-3 and CEg5-4, respectively. CEg5-5 follows a similar trend with 87% Eg5
expression before UV irradiation, indicating a virtually
inactive siRNA agent, and restoration of Eg5 silencing
to native levels through irradiation, with only 8% Eg5
expression detected after UV exposure.
DISCUSSION
The development of light-regulated siRNA molecules
affords precise activation of RNA interference with
widespread applications in the regulation and investigation
of gene function and expression. Here, we set out to achieve
full inactivation of siRNA function using a robust
nucleobase caging technology and demonstrate that this
methodology can be applied to the optochemical regulation
of both exogenous and endogenous genes in mammalian
cells.
To achieve this goal, synthetic routes to two new
NPOM-caged phosphoramidites, the NPOM-caged
uridine 7 and the NPOM-caged guanosine 13, were developed. Guided by the established RNAi mechanism
(52), siRNA sequence analysis (47) and RISC structural
studies (30), the two phosphoramidites were site-speciﬁcally incorporated at deﬁned residues within siRNA oligonucleotides. Two different strategies were tested: (i) By
installing caged uridine nucleotides within the seed
region of the siRNA molecule (nucleotides 2–8), it was
expected that the caging groups would suppress the recognition of the target mRNA while maintaining stability
of the siRNA duplex under physiological conditions.
(ii) Caged guanosine and uridine nucleotides were
introduced within the central argonaute-cleavage region
of different siRNA reagents. Several studies have shown
that base pair mismatches and chemical modiﬁcation at
nucleotide positions 10–11 of an siRNA antisense strand
diminishes RNAi activity (32,47,53).
Tm of the caged RNA oligonucleotides hybridized to
their complementary sequences were measured to determine that the placement of the caging groups will inhibit

only essential RNA:mRNA hydrogen bonding interactions or protein function within RISC, but does not
prevent hybridization of the siRNA duplexes.
Gratifyingly, the introduction of only 1–2 caging groups
does not prevent RNA:RNA hybridization at physiological temperatures and only slightly lowers the Tm of
the 19 nucleotide siRNA duplexes by 1–14 C. A greater
decrease in Tm is observed when the caging group is placed
within the central region of the duplex, in agreement with
previous studies on caged DNA:DNA duplexes (48).
The caged siRNA molecules were subsequently tested
in mammalian cell culture for the photoregulation of
GFP reporter expression. The installation of 1–2 NPOMcaging groups within the central region (positions 9–11) of
the siRNAs CGFP-1 and CGFP-2 completely inhibited
siRNA activity (2–17%), presumably by preventing
the cleavage mechanism within the RISC complex.
Furthermore, brief UV irradiation restored siRNA
function to 75–80% when compared to the negative
control siRNA reagent (see Figure 2). Caging the central
region of the siRNA is an excellent strategy to control
siRNA function with light; however, not all siRNAs
induce RNA cleavage (41) and caging the seed region
may provide a more universal approach to the optochemical regulation of non-coding RNA function. The
seed region plays a very important role in the recognition
of the mRNA target. Thus, in a second light-regulation
approach, NPOM-caged nucleotides were synthetically
introduced within positions 2–7 of the seed region of the
siRNA sequences (see Figure 1). The presence of 1–2
caging groups inhibited RNAi activity until UV irradiation
removed the caging groups and restored active siRNA
molecules. For example, CGFP-3 siRNA shows excellent
photoswitching ability from an inactive siRNA molecule to
an active siRNA reagent through UV exposure, inducing
gene silencing comparable to a non-caged GFP siRNA.
The caged nucleotides were also incorporated into an
siRNA reagent targeting an endogenous gene, Eg5. The
photoactivation of Eg5 inhibition conﬁrmed the ﬁndings
from the GFP reporter studies and demonstrates for the
ﬁrst time that these photochemical tools can be used for the
regulation of endogenous genes.
Interestingly, Mikat et al. previously reported an NPPcaged deoxyguanosine nucleotide that was incorporated at
the third position of the antisense strand (within the seed
region) of GFP siRNA that still displayed substantial
RNA-silencing activity (35). This is in contrast to the
ﬁndings presented here where the incorporation of an
NPOM-caged uridine at the fourth and ﬁfth positions of
the antisense strand (CGFP-3 and CGFP-4) resulted in
80–90% inhibition of siRNA activity. In addition, the
caging groups on the siRNA duplexes maintain stability
for at least 48 h, in contrast to previously reported, less
stable NPP-caged siRNAs that regained silencing activity
after a 28-h incubation in mammalian cells in the dark
(35). The difference in the caged siRNA activity may be
the result of various effects, including the use of different
caging group structures and their different installation on
the nucleobases (N-NPOM versus O-NPP). The higher
stability of the NPOM group installed at the uridine N3
and the guanosine N1 was also observed during
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oligonucleotide synthesis. The fact that actual caged RNA
nucleotides are used here, rather than caged DNA nucleotides, may also have an effect.
Other previously reported caged siRNA reagents were
generated by installing DMNPE groups on the terminal
phosphates of dsRNA to block dicer activity (54).
Additionally, the DMNPE caging group has been statistically incorporated into siRNA (55) and 20 -ﬂuorosubstituted siRNA reagents (34). In all of these studies,
complete inhibition of siRNA activity was not achieved,
as 15–40% of residual siRNA activity was observed.
However, full siRNA function (80–100%) was restored
after UV irradiation. One limitation to these lightactivated RNAi reagents is the statistical incorporation
of the caging group, which may account for the ‘leakiness’
of the caged siRNAs. Recently, Jain et al. introduced
more sterically demanding cyclododecyl DMNPE caging
groups to the four termini of the double-stranded siRNA
and achieved complete inhibition of silencing activity until
UV exposure.(33) Although this methodology provides a
means to regulate RNAi function with light, no sequence/
structure-function information is gained from the placement of the caging groups. Through the site-speciﬁc
incorporation of caged nucleobases, one to two essential
nucleotides can be used to photoregulate siRNA activity
with no background leakiness and full restoration of
siRNA function after UV irradiation (see Figures 2G
and 4). Moreover, depending on the position of the
caged nucleotide in the RNA sequence, different functions—RISC activity versus seed recognition—may be
optochemically regulated to control gene silencing by
siRNAs and miRNAs.
In summary, we have developed novel light-activated
siRNA reagents through the site-speciﬁc introduction of
new nucleobase-caged RNA nucleotides into oligonucleotides. Two new NPOM-caged RNA phosphoramidites,
bearing caging groups with red-shifted absorption
maxima, were synthesized and were successfully
incorporated into RNA using standard automated solidphase oligonucleotide synthesis. Hybridization studies
showed that the presence of one or two caging groups
led to a slightly lower Tm of the siRNA duplex but did
not prevent RNA:RNA hybridization. The activity and
light-regulation of the caged siRNAs were assayed with
a reporter gene, GFP, and an endogenous gene, Eg5.
Through the incorporation of one or two caging groups
within the central nucleotides 8–11 of the antisense strand
of the siRNA, the siRNA reagent was rendered completely inactive, presumably due to the temporary
blocking of argonaute function (56). However, after irradiation, the caging groups were removed, and the
siRNAs were fully functional, leading to efﬁcient gene
silencing in mammalian cells. A second successful caging
strategy that involves incorporation of caged RNA
nucleotides into the seed region of siRNAs should be
easily adapted to the optochemical control of miRNAs,
as those also rely on the seed region for recognition of the
target mRNAs but do not induce argonaute-catalyzed
mRNA cleavage (30). These nucleobase-caged RNA molecules can be used to study the spatial and temporal
dynamics of miRNA function. The dynamic behavior of

miRNAs is becoming increasingly evident in developmental processes, especially in the brain (57), and the
developed approach will provide an excellent tool for
localized cellular and sub-cellular activation of miRNA
function. Additionally, the kinetics of the siRNA and
miRNA pathways can be evaluated, as the time required
for RNA transfection can be separated from the time
needed for a functional output. The light-activation
strategy presented here is not only expected to allow for
silencing of a wide range of genes in mammalian tissue
culture, but also in multicellular organisms with a functional siRNA or miRNA pathway, such as plants (58),
Caenorhabditis elegans (59), drosophila (60) and mice (61).
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